Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.
| Revenue (Most Recent Fiscal Year) | $1.12B |
| Net Income (Most Recent Fiscal Year) | $78.30M |
| PE Ratio (Current Year Earnings Estimate) | 3.37 |
| PE Ratio (Trailing 12 Months) | 3.80 |
| PEG Ratio (Long Term Growth Estimate) | 0.61 |
| Price to Sales Ratio (Trailing 12 Months) | 0.52 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 2.89 |
| Pre-Tax Margin (Trailing 12 Months) | 5.10% |
| Net Margin (Trailing 12 Months) | 4.89% |
| Return on Equity (Trailing 12 Months) | -19.67% |
| Return on Assets (Trailing 12 Months) | 12.27% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.48 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.83 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 2.27 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-12.80 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.70 |
| Earnings per Share (Most Recent Fiscal Year) | $2.45 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.90 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 58.44M |
| Free Float | 58.20M |
| Market Capitalization | $563.39M |
| Average Volume (Last 20 Days) | 0.68M |
| Beta (Past 60 Months) | 1.13 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.42% |
| Percentage Held By Institutions (Latest 13F Reports) | 93.83% |
| Annual Dividend (Based on Last Quarter) | $0.60 |
| Dividend Yield (Based on Last Quarter) | 6.22% |